B.G. Taal

728 total citations
21 papers, 538 citations indexed

About

B.G. Taal is a scholar working on Epidemiology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B.G. Taal has authored 21 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Neurology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B.G. Taal's work include Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (6 papers) and Liver Diseases and Immunity (6 papers). B.G. Taal is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (6 papers) and Liver Diseases and Immunity (6 papers). B.G. Taal collaborates with scholars based in Netherlands, Sweden and Belgium. B.G. Taal's co-authors include Cornelis A. Hoefnagel, P. van Heerde, J. M. V. Burgers, R.A. Valdés Olmos, Henk Boot, J. H. Beijnen, R. Somers, Flora E. van Leeuwen, B. Coster and Ailsa Hart and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

B.G. Taal

20 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B.G. Taal Netherlands	12	247	216	164	152	138	21	538
Nobutatsu Takayanagi Japan	11	134 0.5×	152 0.7×	144 0.9×	55 0.4×	24 0.2×	46	454
P. J. Loehrer United States	9	136 0.6×	227 1.1×	191 1.2×	35 0.2×	292 2.1×	18	603
Anne‐Sophie de Lajarte‐Thirouard France	9	238 1.0×	206 1.0×	119 0.7×	16 0.1×	150 1.1×	14	448
Alessio Pellegrinelli Italy	14	284 1.1×	364 1.7×	79 0.5×	49 0.3×	188 1.4×	23	519
Naofumi Eriguchi Japan	16	201 0.8×	324 1.5×	385 2.3×	72 0.5×	22 0.2×	60	716
Katherine Yao United States	11	184 0.7×	335 1.6×	151 0.9×	128 0.8×	128 0.9×	16	618
David Dusenbery United States	12	91 0.4×	178 0.8×	227 1.4×	123 0.8×	38 0.3×	23	458
Kvols Lk United States	10	341 1.4×	420 1.9×	67 0.4×	28 0.2×	244 1.8×	22	577
M. Penz Austria	7	33 0.1×	293 1.4×	337 2.1×	192 1.3×	43 0.3×	10	524
Hisao Matsunou Japan	10	188 0.8×	360 1.7×	314 1.9×	97 0.6×	89 0.6×	19	605

Countries citing papers authored by B.G. Taal

Since Specialization

Citations

This map shows the geographic impact of B.G. Taal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.G. Taal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.G. Taal more than expected).

Fields of papers citing papers by B.G. Taal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.G. Taal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.G. Taal. The network helps show where B.G. Taal may publish in the future.

Co-authorship network of co-authors of B.G. Taal

This figure shows the co-authorship network connecting the top 25 collaborators of B.G. Taal. A scholar is included among the top collaborators of B.G. Taal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.G. Taal. B.G. Taal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerven, Marcel van, Francisco Javier Díez, B.G. Taal, & Peter Lucas. (2006). Prognosis of High-Grade Carcinoid Tumors using Dynamic Limited Memory Influence Diagrams. 65–70. 1 indexed citations

Taal, B.G. & Maarten L. J. Smits. (2005). Developments in diagnosis and treatment of metastatic midgut carcinoid tumors. A review.. PubMed. 51(4). 335–44. 8 indexed citations

Zuetenhorst, Johanna M., R.A. Valdés Olmos, Mirte Muller, Cornelis A. Hoefnagel, & B.G. Taal. (2004). Interferon and meta-iodobenzylguanidin combinations in the treatment of metastatic carcinoid tumours. Endocrine Related Cancer. 11(3). 553–561. 15 indexed citations

Doornum, Gerard J. J. van, Catharina M. Korse, Johannes M.G. Bonfrèr, et al.. (2003). Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. British Journal of Cancer. 88(7). 1095–1100. 46 indexed citations

Westermann, Anneke M., et al.. (2000). Sequence-dependent toxicity profile in modified famtx (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study. Pharmacological Research. 42(2). 151–156. 3 indexed citations

Taal, B.G., et al.. (1999). [The role of genetic factors in the development of gastric cancer].. PubMed. 143(7). 342–6. 2 indexed citations

Taal, B.G., Cornelis A. Hoefnagel, R.A. Valdés Olmos, Henk Boot, & J. H. Beijnen. (1996). Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.. Journal of Clinical Oncology. 14(6). 1829–1838. 87 indexed citations

Taal, B.G., Berthe M.P. Aleman, C.C.E. Koning, & Henk Boot. (1996). Modulation of toxicity following external beam irradiation preceded by high-dose rate brachytherapy in inoperable oesophageal cancer. European Journal of Cancer. 32(10). 1815–1818. 3 indexed citations

Wafelman, Amon R., et al.. (1995). Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance. Nuclear Medicine Communications. 16(9). 767–772. 18 indexed citations

10.

Wafelman, Amon R., Hilde Rosing, Cornelis A. Hoefnagel, et al.. (1994). High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 12(9). 1173–1179. 3 indexed citations

11.

Taal, B.G., Riccardo A. Audisio, Harry Bleiberg, et al.. (1993). Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Annals of Oncology. 4(7). 607–609. 58 indexed citations

12.

Veenhof, C.H.N., Ronald de Wit, B.G. Taal, et al.. (1992). A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour. European Journal of Cancer. 28(1). 75–78. 27 indexed citations

13.

Taal, B.G. & J. M. V. Burgers. (1991). Primary Non-Hodgkin's Lymphoma of the Stomach: Endoscopic Diagnosis and the Role of Surgery. Scandinavian Journal of Gastroenterology. 26(sup188). 33–37. 29 indexed citations

14.

Leeuwen, Flora E. van, R. Somers, B.G. Taal, et al.. (1989). Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.. Journal of Clinical Oncology. 7(8). 1046–1058. 118 indexed citations

15.

Taal, B.G., F.C.A. den Hartog Jager, J. M. V. Burgers, P. van Heerde, & T. L. Tio. (1989). Primary non-Hodgkin's lymphoma of the stomach: Changing aspects and therapeutic choices. European Journal of Cancer and Clinical Oncology. 25(3). 439–450. 40 indexed citations

16.

Taal, B.G., et al.. (1983). Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria.. PubMed. 30(5). 178–82. 34 indexed citations

17.

Taal, B.G., et al.. (1982). Monomeric (7S) IgM in Primary Biliary Cirrhosis. Scandinavian Journal of Gastroenterology. 17(2). 173–175. 4 indexed citations

18.

Henegouwen, G. P. van Berge, K H Brandt, A T Ruben, S W Schalm, & B.G. Taal. (1982). High frequency of lithogenic bile in primary biliary cirrhosis.. PubMed. 25(4). 89–93. 2 indexed citations

19.

Taal, B.G.. (1981). Studies in primary biliary cirrhosis.. PubMed. 24 Suppl 1. 1–30. 5 indexed citations

20.

Taal, B.G., et al.. (1980). Serum IgM in primary biliary cirrhosis. Clinica Chimica Acta. 108(3). 457–463. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact